10-propargyl-10-deazaaminopterin has been researched along with Angioimmunoblastic Lymphadenopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrop, S; Prince, HM; van der Weyden, C | 1 |
| Chihara, D; Davis, RE; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Hosing, C; Lee, HJ; Medeiros, LJ; Miranda, RN; Nastoupil, LJ; Neelapu, SS; Nieto, YL; Noorani, M; Oki, Y; Rodriguez, MA; Romaguera, JE; Samaniego, F; Turturro, F; Wang, M; Westin, JR | 1 |
2 other study(ies) available for 10-propargyl-10-deazaaminopterin and Angioimmunoblastic Lymphadenopathy
| Article | Year |
|---|---|
Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?
Topics: Aminopterin; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell | 2020 |
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Depsipeptides; Disease-Free Survival; Female; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Young Adult | 2017 |